ImmunoGen, Day One Surge On Cancer Drug Updates, But Arcus Crashes
ImmunoGen (IMGN) and Day One Biopharmaceuticals (DAWN) unveiled promising cancer treatment updates over the weekend, leading IMGN stock and DAWN stock to soar Monday. Both updates came during the American Society of Clinical Oncology annual […]